Patents by Inventor Yoshito Ohnishi

Yoshito Ohnishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION
    Publication number: 20220218602
    Abstract: The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ?,?,?-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.
    Type: Application
    Filed: April 4, 2022
    Publication date: July 14, 2022
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshito OHNISHI, Tetsuo OGATA
  • ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION
    Publication number: 20210220384
    Abstract: The present invention provides an FTD and TPI-containing orally administrable pharmaceutical composition which can be orally administered and is stable even under high-humidity conditions. An orally administrable pharmaceutical composition which comprises ?,?,?-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as active ingredients and additives having a critical relative humidity of 85% or more at 25° C. as an excipient.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 22, 2021
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Yoshito OHNISHI
  • ORAL PHARMACEUTICAL COMPOSITION
    Publication number: 20200289411
    Abstract: The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ?,?,?-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl) methyl-2, 4(1H, 3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.
    Type: Application
    Filed: June 1, 2020
    Publication date: September 17, 2020
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshito OHNISHI, Tetsuo OGATA
  • ORAL PARTICULATE ANTITUMOR PREPARATION
    Publication number: 20160151295
    Abstract: An oral particulate antitumor preparation, which allows safe intake of antitumor agents, handling of which could be in many cases dangerous due to their high. pharmacological activity, and has a stability equivalent to that of capsules or tablets, is provided. An oral particulate antitumor preparation, in which a particulate composition containing an antitumor agent is coated with a saccharide other than a cellulose derivative.
    Type: Application
    Filed: February 1, 2016
    Publication date: June 2, 2016
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshito Ohnishi, Tetsuo OGATA
  • ORAL PHARMACEUTICAL COMPOSITION
    Publication number: 20140363512
    Abstract: The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ?,?,?-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.
    Type: Application
    Filed: February 14, 2013
    Publication date: December 11, 2014
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshito Ohnishi, Tetsuo Ogata
  • ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION
    Publication number: 20140356431
    Abstract: The present invention provides an FTD and TPI-containing orally administrable pharmaceutical composition which can be orally administered and is stable even under high-humidity conditions. An orally administrable pharmaceutical composition which comprises ?,?,?-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as active ingredients and additives having a critical relative humidity of 85% or more at 25° C. as an excipient.
    Type: Application
    Filed: February 14, 2013
    Publication date: December 4, 2014
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventor: Yoshito Ohnishi
  • DRY-COATED TABLET CONTAINING TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM
    Publication number: 20140335174
    Abstract: The present invention provides a dry-coated tablet comprising: an inner core containing, as active ingredients, (a) tegafur, (b) gimeracil, and (c) oteracil potassium; and an outer shell.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 13, 2014
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Takumi Okamoto, Takashi Yoshizawa, Yoshito Ohnishi
  • ORAL PARTICULATE ANTITUMOR PREPARATION
    Publication number: 20100266706
    Abstract: An oral particulate antitumor preparation, which allows safe intake of antitumor agents, handling of which could be in many cases dangerous due to their high pharmacological activity, and has a stability equivalent to that of capsules or tablets, is provided. An oral particulate antitumor preparation, in which a particulate composition containing an antitumor agent is coated with a saccharide other than a cellulose derivative.
    Type: Application
    Filed: December 26, 2008
    Publication date: October 21, 2010
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Yoshito Ohnishi, Tetsuo Ogata